| Ingredients | Not Present |
|---|---|
| 25 mg |
Sugar, Medium Chain Triglyceride (Alt. Name: MCT), Hemp Extract, Tapioca, Corn Syrup, Pear puree concentrate, Corn Starch, Modified, Fructose, Maltodextrin, Palm Oil, Cottonseed Oil PlantPart: seed, Glycerin, Grape juice concentrate, Carrageenan, Citric Acid, Monoglycerides, Sodium Citrate (Alt. Name: Na Citrate), Malic Acid, Vitamin C (Form: Ascorbic Acid), Natural Flavors, Potassium Citrate (Alt. Name: K Citrate), Agar, Xanthan Gum, Red 40, Blue 1, Yellow 5, Yellow 6
Below is general information about the effectiveness of the known ingredients contained in the product Slushers. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
INSUFFICIENT RELIABLE EVIDENCE to RATE
(Read more about DELTA-8-TETRAHYDROCANNABINOL (DELTA-8-THC))
Below is general information about the safety of the known ingredients contained in the product Slushers. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
There is insufficient reliable information available about the safety of delta-8-THC.
CHILDREN: POSSIBLY UNSAFE
when used orally.
Delta-8-THC-containing gummies and other products resembling candy or cookies have been mistakenly consumed by children, resulting in hospital admission (106107,106108,107322,113033). Deep sedation with low blood pressure and a slowed heart rate have occurred (106108,107322).
PREGNANCY AND LACTATION:
Insufficient reliable information available; avoid using.
(Read more about DELTA-8-TETRAHYDROCANNABINOL (DELTA-8-THC))
Below is general information about the interactions of the known ingredients contained in the product Slushers. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Below is general information about the adverse effects of the known ingredients contained in the product Slushers. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General
...There is limited information available about the safety of delta-8-THC.
A thorough evaluation of safety outcomes has not been conducted.
Most Common Adverse Effects:
Orally: Anxiety, cough, difficulty thinking and speaking, dream-like state, euphoria, feeling "high", paranoia, and vision and time distortion.
Serious Adverse Effects (Rare):
Orally: Brugada EKG pattern, cannabinoid hyperemesis syndrome (CHS).
Cardiovascular ...An otherwise healthy 31-year-old male experienced sudden onset substernal, non-exertional chest pain within 20 minutes of taking a gummy containing delta-8-THC. Brugada type I pattern was noted on EKG, with notable progression from a baseline EKG 2 months prior that showed Brugada type III pattern. EKG returned to baseline by 16 hours post-ingestion and the Brugada pattern ultimately resolved by one-month follow up (107323). Three cases report tachycardia in pediatric patients after unintentional ingestion of delta-8-THC that resolved with supportive care (113033,113042).
Gastrointestinal ...A 38-year-old female developed cannabinoid hyperemesis syndrome (CHS) after taking gummies containing delta-8-THC most nights of the week for approximately one month. Symptoms resolved almost immediately after treatment with topical capsaicin cream and intravenous haloperidol 5 mg (106104). A case in a 6-year-old female reports nausea and vomiting after ingestion of delta-8-THC gummies that resolved over 2 days with supportive care (113042).
Neurologic/CNS ...Delta-8-THC has been reported to cause psychoactive effects and a feeling of being "high". It is estimated to be 50% to 75% as psychoactive as delta-9-THC, the primary psychoactive constituent of cannabis. Effects include euphoria, vision and time distortion, difficulty thinking and speaking, and a dream-like feeling (106100,106107,106108). A large case series reports neurologic disorders (e.g., dizziness, somnolence, altered consciousness) as some of the most frequently noted adverse effects with delta-8-THC after assessing a public forum of 98,700 subscribers (113017). Of 183 adverse events related to delta-8-THC reported to the US Food and Drug Administration, 16 report occurrence of seizure (113026). A 2-year-old child presented with sedation and acute encephalopathy requiring intubation following accidental ingestion of gummies containing an estimated delta-8-THC dose of 15 mg/kg. Resolution occurred after approximately 1.5 days of supportive care (107322). Six cases in pediatric patients, ranging from 18 months old to 16 years old, report 5 ingestions and 1 inhalation of delta-8-THC resulting in neurologic presentations (e.g., lethargy, somnolence, agitation, dizziness, unresponsiveness, or possible seizure) requiring supportive care. Resolution occurred over 2 days in most cases (113033,113042).
Psychiatric ...A large case series reports psychiatric disorders as some of the most frequently noted adverse effects with delta-8-THC after assessing a public forum of 98,700 subscribers. Furthermore, anxiety and paranoia were 2 of the most cited adverse effect terms, about 16% and 9%, respectively (113017). Additionally, 3 cases report psychosis in adults after ingesting or inhaling delta-8-THC. All 3 patients required admission to a psychiatric hospital and antipsychotic medications prior to discharge. However, 2 of the patients had underlying psychiatric histories (113047).
Pulmonary/Respiratory ...A large case series reports pulmonary disorders g., cough, dry throat, dyspnea, painful respiration) as some of the most frequently noted adverse effects with delta-8-THC after assessing a public forum of 98,700 subscribers (113017). Of 183 adverse events related to delta-8-THC reported to the US Food and Drug Administration, 33 report dyspnea, 17 report respiratory disorder, and 15 report cough (113026). Additionally, 2 cases in pediatric patients report slowed respiratory breathing with varying initial presentations of somnolence and agitation after ingesting delta-8-THC in the form of candy at doses of 16 mg/kg and 38 mg/kg. Resolution occurred in both cases with supportive care and intensive care admission for approximately 2 days (113033).
Other ...Based on statistics from the American Association of Poison Control Centers, hospitalization occurred in 18% of 661 reported exposures to delta-8-THC in the first 7 months of 2021 (106108). In the 8-month period ending in July 2021, 14 of 22 cases reported to the US FDA presented to the hospital for adverse effects related to delta-8-THC-containing products (106107). In addition, the CDC's National Syndromic Surveillance Program (NSSP) has found an increase in visits to emergency departments due to complaints related to delta-8-THC (106108). Symptoms of delta-8-THC intoxication include vomiting, lethargy, hallucinations, lack of muscle coordination, increased and decreased heart rate, low blood pressure, difficulty breathing, and coma (106107,106108,107322).
(Read more about DELTA-8-TETRAHYDROCANNABINOL (DELTA-8-THC))
